A survey of impulse control disorders in Parkinson’s disease patients in Shanghai area and literature review

BACKGROUND: Levodopa and dopamine agonists are the main treatments for Parkinson’s disease (PD) in recent years. Increased drug dosages are linked to some severe side effects, one of which is impulse control disorders (ICD). Many studies have reported the related risk factors of ICDs, such as dopami...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Xue-Ping, Wei, Ming, Xiao, Qin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4758007/
https://www.ncbi.nlm.nih.gov/pubmed/26893825
http://dx.doi.org/10.1186/s40035-016-0051-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4758007/
https://www.ncbi.nlm.nih.gov/pubmed/26893825
http://dx.doi.org/10.1186/s40035-016-0051-7

Ejemplares similares